Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 10, 2020

SELL
$3.95 - $5.35 $38,713 - $52,435
-9,801 Closed
0 $0
Q4 2018

Feb 08, 2019

SELL
$1.61 - $3.62 $1,081 - $2,432
-672 Reduced 6.42%
9,801 $18,000
Q3 2018

Nov 13, 2018

SELL
$2.26 - $3.27 $219 - $317
-97 Reduced 0.92%
10,473 $34,000
Q1 2018

May 04, 2018

SELL
$3.46 - $5.14 $4,404 - $6,543
-1,273 Reduced 10.75%
10,570 $41,000
Q3 2017

Nov 07, 2017

BUY
$4.99 - $6.57 $59,096 - $77,808
11,843
11,843 $73,000

Others Institutions Holding TCRT

About Alaunos Therapeutics, Inc.


  • Ticker TCRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,182,000
  • Market Cap $458M
  • Description
  • Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...
More about TCRT
Track This Portfolio

Track First Washington Corp Portfolio

Follow First Washington Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Washington Corp, based on Form 13F filings with the SEC.

News

Stay updated on First Washington Corp with notifications on news.